Clinical trial
Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2…
NCT00148668 · Eric Winer, MD, Other · Completed
Key facts
| NCT number | NCT00148668 |
|---|---|
| Title | Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer |
| Official title | A Randomized Phase II Study of Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in Early Stage, HER-2 Positive Breast Cancer |
| Lead sponsor | Eric Winer, MD, Other |
| Collaborators | Dana-Farber Cancer Institute Brigham and Women's Hospital Massachusetts General Hospital Beth Israel Deaconess Medical Center Yale University |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Herceptin, Navelbine, Taxotere, Carboplatin |
| Enrollment | 81 |
| Start date | Dec 1, 2003 |
| Primary completion | Jan 1, 2009 |
| Completion | Aug 1, 2011 |
| First posted | Sep 8, 2005 |
| Last update posted | Apr 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: